Aap Implantate AG Stock
Price
Target price
€1.45
€1.45
4.960%
0.07
4.960%
€2.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Aap Implantate AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Aap Implantate
sharewise wants to provide you with the best news and tools for Aap Implantate, so we directly link to the best financial data sources.
Financials
News
EQS-News: aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
EQS-News: aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
EQS-News: aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
EQS-News: aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
EQS-News: aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
EQS-News: aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
EQS-Adhoc: aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier
EQS-Adhoc: aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier
EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
More than 100 patients included in the human clinical trial by 31 December 2023; adapted study design meets expectations for accelerated patient recruitment
More than 100 patients included in the human clinical trial by 31 December 2023; adapted study design meets expectations for accelerated patient recruitment
EQS-News: aap concludes distribution agreement for LOQTEQ® VA Radius System with leading global spine and orthopedics company
EQS-News: aap concludes distribution agreement for LOQTEQ® VA Radius System with leading global spine and orthopedics company
EQS-Adhoc: Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation of a personnel measure to achieve positive EBITDA and balanced cash flow in the operating trauma business
EQS-Adhoc: Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation of a personnel measure to achieve positive EBITDA and balanced cash flow in the operating trauma business